NCT06081452 Public Survey on Breath Testing for Health and Disease
| NCT ID | NCT06081452 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Imperial College London |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-06-17 |
| Primary Completion | 2025-06-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-06-17 with a primary completion date of 2025-06-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A brief survey for the public to determine interest in health surveillance and disease detection
Eligibility Criteria
Inclusion Criteria: * Member of the public above the age of 18 Exclusion Criteria: * Member of the public below the age of 18
Contact & Investigator
George Hanna, PhD
STUDY DIRECTOR
Imperial College London
Frequently Asked Questions
Who can join the NCT06081452 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06081452 currently recruiting?
Yes, NCT06081452 is actively recruiting participants. Contact the research team at h.arya@imperial.ac.uk for enrollment information.
Where is the NCT06081452 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06081452 clinical trial?
NCT06081452 is sponsored by Imperial College London. The principal investigator is George Hanna, PhD at Imperial College London. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.